Abstract:Tissue engineering is a promising technique for cartilage repair, but to optimize novel scaffolds before clinical trials, it is necessary to determine their characteristics for binding and release of growth factors. Toward this goal, a novel, porous collagen-glycosaminoglycan scaffold was loaded with a range of concentrations of insulinlike growth factor-1 (IGF-1) to evaluate its potential as a controlled delivery device. The kinetics of IGF-1 adsorption and release from the scaffold was demonstrated using rad… Show more
“…27 Furthermore, PRP added to collagen matrix was able to increase the expression of collagen, elastin, and aggrecan genes which constitute key structural components of the menisci. This in vitro data suggests that there may be a small benefit to adding PRP to a minor meniscal defect where there is a possibility of the PRP to accumulate.…”
Section: Discussionmentioning
confidence: 99%
“…14,15,[22][23][24] Furthermore, collagen contains numerous biologically relevant binding motifs 22,25 and has been investigated for its ability to act as a local reservoir and mediator of biologically active materials such as IGF-1 or platelet rich plasma (PRP). 26,27 Collagen/glycosaminoglycan matrices have previously been used by us to examine uptake and delivery of IGF-1 over extended time periods to influence the growth and synthetic capabilities of human articular chondrocytes. 27 IGF-1, TGFb1, and PDGF have been demonstrated to influence meniscal fibroblasts by increasing expression of matrix proteins such as collagens and proteoglycans.…”
mentioning
confidence: 99%
“…26,27 Collagen/glycosaminoglycan matrices have previously been used by us to examine uptake and delivery of IGF-1 over extended time periods to influence the growth and synthetic capabilities of human articular chondrocytes. 27 IGF-1, TGFb1, and PDGF have been demonstrated to influence meniscal fibroblasts by increasing expression of matrix proteins such as collagens and proteoglycans. 28,29 These and other growth factors can be concentrated from the blood with the production of PRP.…”
Damage to meniscal cartilage has been strongly linked to accelerated articular wear and consequently to osteoarthritis. Damage might be ameliorated by delivery of growth factors from platelet rich plasma (PRP) via a fiber reinforced collagen matrix designed for meniscal repair. PRP composition, release of growth factors, and influence on meniscal cell growth and gene expression were investigated. PRP was prepared using Harvest Smartprep (HS-PRP), Cascade Fibrinet (CF-PRP), and a simple centrifuge protocol (DC-PRP) from four donors each. CF-PRP had the highest ratio of platelets, with very few other blood cell types. HS-PRP had the highest total number of platelets but also contained high levels of red and white blood cells. Absorbed to collagen matrices HS-PRP released the highest levels of TGF-b1 and PDGF-AB with DC-PRP the most IGF-1. Cumulative release from collagen matrix was 48 ng/ cm 3 IGF-1, 96 ng/cm 3 TGF-b1, and 9.6 ng/cm 3 PDGF-AB. Collagen matrix with PRP was able to increase meniscal cell number above peripheral whole blood and up-regulated gene expression of Aggrecan, Collagen type I (a1), and Elastin (3.3 AE 0.8-fold, 2.9 AE 0.6-fold, 4.0 AE 1.4-fold, respectively). Demonstrating that PRP combined with fiber reinforced collagen matrix could influence meniscal cells and might be of use for treating meniscal defects. ß
“…27 Furthermore, PRP added to collagen matrix was able to increase the expression of collagen, elastin, and aggrecan genes which constitute key structural components of the menisci. This in vitro data suggests that there may be a small benefit to adding PRP to a minor meniscal defect where there is a possibility of the PRP to accumulate.…”
Section: Discussionmentioning
confidence: 99%
“…14,15,[22][23][24] Furthermore, collagen contains numerous biologically relevant binding motifs 22,25 and has been investigated for its ability to act as a local reservoir and mediator of biologically active materials such as IGF-1 or platelet rich plasma (PRP). 26,27 Collagen/glycosaminoglycan matrices have previously been used by us to examine uptake and delivery of IGF-1 over extended time periods to influence the growth and synthetic capabilities of human articular chondrocytes. 27 IGF-1, TGFb1, and PDGF have been demonstrated to influence meniscal fibroblasts by increasing expression of matrix proteins such as collagens and proteoglycans.…”
mentioning
confidence: 99%
“…26,27 Collagen/glycosaminoglycan matrices have previously been used by us to examine uptake and delivery of IGF-1 over extended time periods to influence the growth and synthetic capabilities of human articular chondrocytes. 27 IGF-1, TGFb1, and PDGF have been demonstrated to influence meniscal fibroblasts by increasing expression of matrix proteins such as collagens and proteoglycans. 28,29 These and other growth factors can be concentrated from the blood with the production of PRP.…”
Damage to meniscal cartilage has been strongly linked to accelerated articular wear and consequently to osteoarthritis. Damage might be ameliorated by delivery of growth factors from platelet rich plasma (PRP) via a fiber reinforced collagen matrix designed for meniscal repair. PRP composition, release of growth factors, and influence on meniscal cell growth and gene expression were investigated. PRP was prepared using Harvest Smartprep (HS-PRP), Cascade Fibrinet (CF-PRP), and a simple centrifuge protocol (DC-PRP) from four donors each. CF-PRP had the highest ratio of platelets, with very few other blood cell types. HS-PRP had the highest total number of platelets but also contained high levels of red and white blood cells. Absorbed to collagen matrices HS-PRP released the highest levels of TGF-b1 and PDGF-AB with DC-PRP the most IGF-1. Cumulative release from collagen matrix was 48 ng/ cm 3 IGF-1, 96 ng/cm 3 TGF-b1, and 9.6 ng/cm 3 PDGF-AB. Collagen matrix with PRP was able to increase meniscal cell number above peripheral whole blood and up-regulated gene expression of Aggrecan, Collagen type I (a1), and Elastin (3.3 AE 0.8-fold, 2.9 AE 0.6-fold, 4.0 AE 1.4-fold, respectively). Demonstrating that PRP combined with fiber reinforced collagen matrix could influence meniscal cells and might be of use for treating meniscal defects. ß
“…12,32-50 (3) Bioactive factors directly dispersed, immobilized, or adsorbed into the three-dimensional construct. 3,4,[6][7][8][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68] The level of immobilization determines the release rate of GFs and consequently their effect on tissue formation. Several studies approach a particularly relevant immobilization method, mimicking native extracellular matrix (ECM), affinity-bound systems, through the inclusion of heparin domains on the structure, thus expecting an enhanced stability of the entrapped GF.…”
The development of controlled release systems for the regeneration of bone, cartilage, and osteochondral interface is one of the hot topics in the field of tissue engineering and regenerative medicine. However, the majority of the developed systems consider only the release of a single growth factor, which is a limiting step for the success of the therapy. More recent studies have been focused on the design and tailoring of appropriate combinations of bioactive factors to match the desired goals regarding tissue regeneration. In fact, considering the complexity of extracellular matrix and the diversity of growth factors and cytokines involved in each biological response, it is expected that an appropriate combination of bioactive factors could lead to more successful outcomes in tissue regeneration. In this review, the evolution on the development of dual and multiple bioactive factor release systems for bone, cartilage, and osteochondral interface is overviewed, specifically the relevance of parameters such as dosage and spatiotemporal distribution of bioactive factors. A comprehensive collection of studies focused on the delivery of bioactive factors is also presented while highlighting the increasing impact of platelet-rich plasma as an autologous source of multiple growth factors.
“…Producing collagen scaffolds by ice-templating has proven to be a very successful technique for tissue engineering, enabling cell culture to move from two-dimensional substrates towards three-dimensional scaffolds. They can be used for maintenance of cell phenotype in long term culture, creation of more effective drug delivery devices, and studies of whole tissue morphogenesis [6][7][8] .…”
In recent years, there has been a shift from traditional cell culture on two-dimensional substrates towards the use of three-dimensional scaffolds for tissue engineering. Ice-templating is a versatile tool to create porous scaffolds from collagen. Here we discuss specific considerations for the design of moulds to produce freeze dried collagen scaffolds with pore sizes of around 100µm, a range that is relevant to tissue engineering. A numerical model of heat conduction, implemented in COMSOL Multiphysics® version 5.0, calculated the temperature contour lines and heat flow vectors during cooling for a variety of mould geometries and materials. We show how temperature distribution within moulds determines the resulting pore structure of the scaffolds by regulating ice growth, and we validate our simulation against experimental results. These simulations are especially useful when working with moulds that contain volumes of more than 1cm in each direction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.